Mode
Text Size
Log in / Sign up
N/A N=130 Randomized Double-blind Diagnostic

Telemedicine Optimized Burn Intervention

Burns · Pediatric ALL

Enrolled (actual)
130
Serious AEs
0.0%
Results posted
Jul 2025
Primary outcome: Primary: Number of Participants Who Agree to Participate in the Study — 66; 64 participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Face-to-face burn care (Procedure); Telemedicine enhanced burn care (Procedure)
Age
Pediatric, Adult, Older Adult · 0+ yrs
Sex
All
Sponsor
Medical University of South Carolina
Primary completion
Mar 2024

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Participants Who Agree to Participate in the Study
66; 64
PRIMARY
Number of Participants Retained in the Study Over Time
36; 42
PRIMARY
Wound Care Treatment Adherence
76.8; 84.9
PRIMARY
Number of Child Participants That Experienced Adverse Events, Serious Adverse Events, and Unexpected Problems
0; 0
PRIMARY
Number of Times Problems With Technology Happened in the TOBI Condition
1
SECONDARY
Number of Days Until Wound is Healed
11.5; 11.4
SECONDARY
Number of Unscheduled ED or Clinic Visits
0; 2
SECONDARY
Number of Wound Complications
0; 0
SECONDARY
Patient-reported Pain Scores
3.1; 1.8
SECONDARY
Caregiver's Perception of Child's Pain Scores
3.1; 1.8
SECONDARY
Attitudes Towards Technology and Telemedicine Questionnaire
79.5; 78.0
SECONDARY
Perception of Healthcare Access
64.5; 72.6
SECONDARY
Positive And Negative Affect Schedule (PANAS) Scores
37; 32; 14; 13; 35; 33
SECONDARY
Patient-Reported Outcomes Measurement Information System - Depression (PROMIS-Depression) Scores
47.5; 47.5; 47.5; 44.9
SECONDARY
Patient-Reported Outcomes Measurement Information System - Anxiety (PROMIS-Anxiety) Scores
50.7; 47.8; 50.4; 46.8
SECONDARY
Patient-Reported Outcomes Measurement Information System - General Self-Efficacy (PROMIS-General-Self-Efficacy) Scores
53.5; 53.2
SECONDARY
Patient-Reported Outcomes Measurement Information System - Self-Efficacy to Manage Emotions (PROMIS-Self-Efficacy-Manage-Emotions) Scores
50.2; 50.7
SECONDARY
Peritraumatic Distress Inventory (PDI) Sores
11.9; 13.8
SECONDARY
Perceived Stress Scale (PSS) Scores
18.6; 19.4
SECONDARY
Posttraumatic Growth Inventory (PTGI) Scores
54.7; 39.5
SECONDARY
Client Satisfaction Questionnaire-8 (CSQ-8) Scores
30.8; 30.5
SECONDARY
mHealth App Usability Questionnaire (MAUQ) Scores
6.3
SECONDARY
Total Number of Face-to-face Visits
2.1; 1.1
SECONDARY
Total Number of TOBI Visits
1.1
SECONDARY
Total Travel Time
4.0; 2.3
SECONDARY
Direct Cost to Patient/Caregiver
339.10; 258.81
SECONDARY
Time to Return to Work
2.0; 1.3

Summary

Because burn patients and their caregivers often live long distances from regional burn centers, access to expert burn care is limited, resulting in a negative effect on adherence to treatment and a higher risk of wound complication. A novel smartphone application synchronized with a web portal for providers, called the Telemedicine Optimized Burn Intervention (TOBI), was recently developed to enable burn experts to direct burn wound care while the patient and caregiver are home through text messaging, image transfer, and video-conferencing. The goal of the present study is evaluate TOBI compared to face-to-face care as usual for pediatric patients/caregivers visiting a burn center. This study will also assess the feasibility of conducting a larger-scale clinical trial in several burn centers. The app will allow the physician and patient/caregivers to make instant decisions regarding treatment, allowing for "turn on a dime" treatment decisions, rather than having the patients and families wait for scheduled clinic appointments, often hours away from home. This "on demand" medical care takes an innovative approach to increasing access to burn experts through smartphone technology and addressing adherence to prescribed treatment by increasing communication between provider and patients.

Eligibility Criteria

Inclusion criteria

Caregiver parents and their children (patients) will be considered as participants and will be eligible for enrollment if:

  • the patient (child) is 18 years of age
  • the patient is diagnosed with a partial thickness burn between <1% TBSA - 20% TBSA by a pediatric burn surgeon;
  • the patient's burn is being treated with advanced burn dressing therapy (e.g., Silvadene™, Polysporin™, Acticoat™, Mepilex™, or Mepitel™);
  • the patient's burn is evaluated by the MUSC burn team within 48 hours of injury;
  • the patient's caregiver (parent or legal guardian) is able to speak, hear, and understand English, as determined during study recruitment procedures;
  • the caregiver owns and is capable of using a smart device (an Android or iOS smartphone) with permission to download TOBI app from the Google Store or AppStore;
  • able to comply with outpatient clinic visits.

Exclusion Criteria

  • There are no exclusion criteria. All participants who meet inclusion criteria would be eligible to participate in the study.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05019144). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search